Protean Funds Scandinavia AB May 2025 Partner Letter
Source: SeekingAlpha
2025-06-04 05:15:00 ET
Summary
- Protean Small Cap outperformed its benchmark, returning 5.5% in May and 48.3% since inception, thanks to an opportunistic, high-turnover approach.
- We see significant upside in Arjo due to low valuation, operational stability, and a new leadership focus on efficiency and core business.
- Investment companies, once attractive at deep discounts, now look overvalued; we expect underperformance as discounts revert to historical norms.
- Our funds prioritize active management, risk/reward, and long-term outperformance, with fee reductions as assets grow and a commitment to investor alignment.
Small caps, big returns - May 2025
Dear Partners,
Protean Small Cap returned 5.5% in May, outperforming its index by 2.5% points. Since launching in June 2023, it has gained 48.3%, which is 28.8%-points ahead of the Carnegie Nordic Small Cap Index....
Read the full article on Seeking Alpha
For further details see:
Protean Funds Scandinavia AB May 2025 Partner Letter
Arjo AB - Class B
NASDAQ: ARRJF
ARRJF Trading
0.0% G/L:
$2.965 Last:
2,000 Volume:
$2.965 Open:
